Susan Hasty, Publisher
Table of Contents . . . March 13th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
Transmission - CD8 T-Cell Response Linked to HIV Protection in Heterosexuals
AIDS Therapies - Impact of Ritonavir on Fat Distribution Studied
AIDS Therapies - Long-Term Zidovudine Linked to Reduced Dementia
AIDS Therapies - Ritonavir Regimen Superior to Nucleoside Analog
Adverse Events - Hyperinsulinemia Occurs in Absence of Protease Inhibitor Use
At-Risk Populations - Secondary HIV Infections Still Declining
Epidemiology - Drug Routes in Asia See HIV Increase
Pathogenesis - Differences in TNF-(alpha) Secretion May Impact Disease Course
Pathology - Brain Involvement Still Common in AIDS Deaths
Testing - HPLC Assay for Common Protease Inhibitors Developed
Transmission - Key Molecule Discovered In Transmission of AIDS Virus
Transmission - Study Examines How Drug Use Impacts HIV Spread
AIDS Therapies - Human Anti-HIV gp41 MAbs Neutralize Multiple Primary HIV Isolates
Anemia - Malaria, HIV Among Risk Factors for Anemia in Kenyan Children
Animal Models - Researchers Report on Rat Model for HIV
DNA Vaccines - Strategy Produces Selective Induction of Th1 and Th2 Cells
Epidemiology - Caribbean AIDS Explosion Examined
HIV Vaccines - Live Poliovirus Vaccine Being Testing Against HIV in Macaques
HIV Vaccines - SF162deltaV2 Envelope Could Further AIDS Vaccine Search
HIV Vaccines - U.S. NIH Reports on Selection of HIV Specific Epitopes
Inhibitors - Discovery of CCR5 Structure That Binds HIV Reported
Clinical Trials - U.S. National Institutes of Health Launches ClinicalTrials.gov Web Site
Industry News - Drug Companies To Donate Vaccines
Infectious Disease - Japan, U.S. Team Up Against AIDS, Other Diseases
Insurance - Clinton Plan May Boost HIV Benefits
Knowledge, Attitudes, and Behavior - Ignorance Could Worsen South Africa AIDS Threat
Testing - FDA Approval Received for Cadaveric Serum Use with Genetic Systems Test Kits
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.